Connection

Thomas Pollak to Magnetic Resonance Imaging

This is a "connection" page, showing publications Thomas Pollak has written about Magnetic Resonance Imaging.
Connection Strength

0.108
  1. Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology (Berl). 2018 07; 235(7):1875-1886.
    View in: PubMed
    Score: 0.054
  2. Letter to the Editor: NMDA receptor autoimmunity in mania following HSV encephalitis. Psychol Med. 2018 05; 48(7):1221-1223.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.